GCC Radiopharmaceuticals Market Grows as Nuclear Medicine Capacity Expands
According to Dimension Market Research, the GCC Radiopharmaceuticals Market is estimated at USD 218.4 million in 2026 and projected to reach USD 682.6 million by 2035, at a 13.5% CAGR. Diagnostics lead revenue, while therapeutics are forecast to grow faster.

